БЛОГ

Archive for the ‘business’ category: Page 160

Mar 19, 2020

Intel to Release Neuromorphic-Computing System

Posted by in categories: business, computing, government, neuroscience

Intel Corp. is releasing an experimental research system for neuromorphic computing, a cutting-edge method that simulates the way human brains work to perform computations faster, using significantly less energy.

The system, called Pohoiki Springs, will be made available this month over the cloud to members of the Intel Neuromorphic Research Community, which includes academic researchers, government labs and about a dozen companies such as Accenture PLC and Airbus SE.

Others, including International Business Machines Corp., are also researching the technique.

Mar 19, 2020

Mnuchin Backs $1,000 Per Adult, $500 Per Child in Payments

Posted by in categories: biotech/medical, business, economics, government

U.S. Treasury Secretary Steven Mnuchin said he supports direct payments of $1,000 per adult and $500 per child to Americans within three weeks if Congress backs the plan.

“The president is determined that we are going to support” those affected, Mnuchin said in a Fox Business interview Thursday morning.

Cash handouts to all American households are gaining support in Congress as the best way to shore up an economy brought to a near-standstill by the coronavirus response.

Mar 19, 2020

Sanofi and Regeneron begin global Kevzara® (sarilumab) clinical trial program in patients with severe COVID-19

Posted by in categories: biotech/medical, business

CAMBRIDGE, Mass. and TARRYTOWN, N.Y., March 16, 2020 /PRNewswire/ — Sanofi and Regeneron Pharmaceuticals, Inc today announced they have started a clinical program evaluating Kevzara® (sarilumab) in patients hospitalized with severe COVID-19. Kevzara is a fully-human monoclonal antibody that inhibits the interleukin-6 (IL-6) pathway by binding and blocking the IL-6 receptor. IL-6 may play a role in driving the overactive inflammatory response in the lungs of patients who are severely or critically ill with COVID-19 infection. The role of IL-6 is supported by preliminary data from a single-arm study in China using another IL-6 receptor antibody.

This U.S.-based trial will begin at medical centers in New York, one of the epicenters of the U.S. COVID-19 outbreak, and will assess the safety and efficacy of adding Kevzara to usual supportive care, compared to supportive care plus placebo. The multi-center, double-blind, Phase 2/3 trial has an adaptive design with two parts and is anticipated to enroll up to 400 patients. The first part will recruit patients with severe COVID-19 infection across approximately 16 U.S. sites, and will evaluate the impact of Kevzara on fever and patients’ need for supplemental oxygen. The second, larger part of the trial will evaluate the improvement in longer-term outcomes including preventing death and reducing the need for mechanical ventilation, supplemental oxygen and/or hospitalization.

“At Sanofi, we are taking a leading role in addressing the global challenge of COVID-19 disease. Scientific evidence has emerged to suggest that Kevzara may be a potentially important treatment option for some patients, and this trial will provide the well-controlled, rigorous scientific data we need to determine if IL-6 inhibition with Kevzara is better than current supportive care alone. Additionally, we expect to rapidly initiate trials outside the U.S. in the coming weeks, including areas most affected by the pandemic such as Italy,” said John Reed, M.D., Ph.D., Sanofi’s Global Head of Research and Development. “In addition to Kevzara, Sanofi Pasteur, the vaccines global business unit of Sanofi, is leveraging previous development work for a SARS vaccine as part of our goal to quickly develop a COVID-19 vaccine.”

Mar 18, 2020

New scanner can improve the detection of cancer tissue and brain disease diagnoses

Posted by in categories: biotech/medical, business, engineering, neuroscience

A group of neuroscience and neurotechnology researchers have conducted extensive research and developed a new brain imaging technology in two EU projects led by Aalto University. As a result of the successful research, a new project funded by Business Finland just started with the aim of making the devices usable for patients. The project’s budget is one million euros.

“More can be helpful in locating epileptic activity before surgery. The new device is also expected to help distinguish brain tumours from healthy tissue more accurately prior to cancer surgery. In addition, the device will increase our understanding of the connections between the different brain regions. This will help us understand abnormal brain activity in connection with, for example, depression or the progress of Alzheimer’s disease,” explains Professor Risto Ilmoniemi, Head of Aalto University Department of Neuroscience and Biomedical Engineering.

The improved accuracy can also be useful in the study of stroke, autism and brain injuries; and especially as part of basic brain research.

Mar 18, 2020

Swans & Dolphins Return To Italy, As Air, Water Quality Improves During Lockdown

Posted by in categories: biotech/medical, business

The increasing number of coronavirus cases in Italy has brought the entire country to a standstill. According to the Live Tracking Dashboard, there are 27,980 confirmed cases as of now and 2,158 people have succumbed to the infection. However, a total of 2,749 people have also recovered from the illness.

Since people are socially distancing themselves to avoid the virus from spreading, a lot of them are also losing business with every passing minute. There’s panic and tension all around. However, there is a piece of good news that’s become the silver lining at this time of misery.

Continue reading “Swans & Dolphins Return To Italy, As Air, Water Quality Improves During Lockdown” »

Mar 17, 2020

SBA to Provide Disaster Assistance Loans for Small Businesses Impacted by Coronavirus (COVID-19)

Posted by in categories: biotech/medical, business, economics

WASHINGTON – SBA Administrator Jovita Carranza issued the following statement today in response to the President’s address to the nation:

“The President took bold, decisive action to make our 30 million small businesses more resilient to Coronavirus-related economic disruptions. Small businesses are vital economic engines in every community and state, and they have helped make our economy the strongest in the world. Our Agency will work directly with state Governors to provide targeted, low-interest disaster recovery loans to small businesses that have been severely impacted by the situation. Additionally, the SBA continues to assist small businesses with counseling and navigating their own preparedness plans through our network of 68 District Offices and numerous Resource Partners located around the country. The SBA will continue to provide every small business with the most effective and customer-focused response possible during these times of uncertainty.”

SBA’s Economic Injury Disaster Loans offer up to $2 million in assistance for a small business. These loans can provide vital economic support to small businesses to help overcome the temporary loss of revenue they are experiencing.

Mar 17, 2020

Yang demands Congress get its ‘sh– together’ and approve payments to all Americans

Posted by in categories: biotech/medical, business, economics, education, geopolitics

Entrepreneur and former presidential candidate Andrew Yang is not being shy about his belief that the impact of the coronavirus outbreak makes the case for his trademark proposal of giving Americans cash so they can have an economic boost.

Yang is now calling on lawmakers to do just that to help people navigate their way through the pandemic that has resulted in governments ordering schools and many businesses to close.

CORONAVIRUS OUTBREAK SPURS NEW YORK, NEW JERSEY, CONNECTICUT TO SHUT BARS, RESTAURANTS AND MOVIE THEATERS

Mar 15, 2020

Battelle-Led Team Wins DARPA Award to Develop Injectable, Bi-Directional Brain Computer Interface

Posted by in categories: biotech/medical, business, government, military, neuroscience, robotics/AI

Here’s an exciting concept that was actually first discussed in 1959 by Richard Feynman in an article entitled “There’s Plenty of Room at the Bottom”.

I am most interested in this technology for mind uploading.

“Battelle’s N3 concept for a minimally invasive neural interface system, called BrainSTORMS (Brain System to Transmit Or Receive Magnetoelectric Signals), involves the development of a novel nanotransducer that could be temporarily introduced into the body via injection and then directed to a specific area of the brain to help complete a task through communication with a helmet-based transceiver.”

Continue reading “Battelle-Led Team Wins DARPA Award to Develop Injectable, Bi-Directional Brain Computer Interface” »

Mar 15, 2020

City of Boulder Issues Local Emergency Declaration

Posted by in categories: biotech/medical, business, health

Disaster emergency is in response to the global COVID-19 pandemic and the effects it is having on the city.

The City of Boulder has declared a local disaster emergency in response to the global COVID-19 pandemic and the effects it is having on the city.

City Manager Jane Brautigam issued a disaster emergency declaration today effective at 6 p.m. This creates a state of emergency for Boulder. The declaration provides the city manager with tools necessary to protect the public health and safety. The City Manager has authority to issue a disaster emergency declaration for a period of up to 7 days. To be effective for more than 7 days, the declaration must be confirmed and extended by the city council. Staff will ask the city council to consider doing so at the March 17, 2020 council meeting. The disaster emergency declaration provides the city manager with the authority to, among other things, order a curfew, limit large gatherings, close streets and sidewalks and order businesses to close. Violation of any emergency order would be punishable by a fine of up to $1000 and up to 90 days in jail.

Mar 15, 2020

Coronavirus will bankrupt more people than it kills — and that’s the real global emergency

Posted by in categories: biotech/medical, business, economics, finance, health

Coronavirus’s economic danger is exponentially greater than its health risks to the public. If the virus does directly affect your life, it is most likely to be through stopping you going to work, forcing your employer to make you redundant, or bankrupting your business.

The trillions of dollars wiped from financial markets this week will be just the beginning, if our governments do not step in. And if President Trump continues to stumble in his handling of the situation, it may well affect his chances of re-election. Joe Biden in particular has identified Covid-19 as a weakness for Trump, promising “steady, reassuring” leadership during America’s hour of need.

Continue reading “Coronavirus will bankrupt more people than it kills — and that’s the real global emergency” »